Cargando...
Comparative Assessment of Protein Kinase Inhibitors in Public Databases and in PKIDB
Since the first approval of a protein kinase inhibitor (PKI) by the Food and Drug Administration (FDA) in 2001, 55 new PKIs have reached the market, and many inhibitors are currently being evaluated in clinical trials. This is a clear indication that protein kinases still represent major drug target...
Gardado en:
| Publicado en: | Molecules |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7397241/ https://ncbi.nlm.nih.gov/pubmed/32679723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules25143226 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|